Found 195 matching trials
Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma NA Study on the therapeutic effect of different infusion times on tislelizumab...
Show More Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China
Learn More & Join Trial
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive PHASE1 Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies EARLY_PHASE1 Current treatments for relapsed/refractory hematopoietic malignancies such ...
Show More Location
Multiple Locations
Learn More & Join Trial
PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer PHASE1 This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma PHASE2 This experiment will test the safety and effectiveness of a treatment for m...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Reduced Intensity Transplantation for Severe Sickle Cell Disease PHASE2 This study is being done to test a transplant method that may have fewer si...
Show More Location
St. Jude Children's Research Hospital
Treatments Being Tested
hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus Learn More & Join Trial
CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor PHASE1 This is a single-arm, open-label, one center clinical study, to determine t...
Show More Location
Ningbo No.5 Hospital (Ningbo Cancer Hospital)
Learn More & Join Trial
Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL PHASE1 This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation PHASE1 The stud will evaluate whether infusions of CD45RA-depleted lymphocytes fro...
Show More Location
Federal Research Center for pediatric hematology, oncology and immunology
Learn More & Join Trial
Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma PHASE2 RATIONALE: Drugs used in chemotherapy such as fludarabine use different way...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial